Navegando por Assunto "Poliquimioterapia"

Agora exibindo 1 - 3 de 3

Acesso aberto (Open Access)
Análise da adesão medicamentosa de pacientes hansenianos em uma Unidade Básica de Saúde
(Universidade Federal do Pará, 2023-06-16) PINHEIRO, Alcivaldo Mendes; MELLO, Amanda Gabryelle Nunes Cardoso; http://lattes.cnpq.br/8951750304102610; https://orcid.org/0000-0001-7661-1615
Introduction: Leprosy is a chronic transmissible infectious disease that still persists as a public health problem in Brazil. However, through the analysis of polychemotherapy medication adherence, a better quality of life is sought for diagnosed leprosy patients, with the pharmacist playing an important role in promoting early diagnosis and rational use of medication. Objective: To analyze the therapeutic adherence of patients undergoing treatment for leprosy treated at a basic health unit in Belém. Methodology: It is a prospective observational study to characterize the sociodemographic profile of patients undergoing polychemotherapy drug treatment at the Basic Health Unit located in the Guamá neighborhood, in Belém do Pará. Results: The study had the participation of 75 patients, 60 were undergoing treatment and 15 had already been discharged, in which the latter were consulted only to assess the dermatological quality of life. For the demographic and economic survey of patients, those who did not have confirmed diagnoses or had not started treatment were excluded. Final considerations: The predominant age group was between 50 and 59 years old, approximately (11.25%), male (41.25%), self-declared black patients (18.75%), married (21, 0%), high school (15.75%) and who had a formal contract with an income of up to one minimum wage (11.25%). Most patients adhered positively to the treatment, and at the end of the research a Therapeutic Adherence Manual was prepared for the follow-up of patients with leprosy, aiming at updating pharmaceutical practices with an exclusive focus on the care of patients with leprosy.
Acesso aberto (Open Access)
Efeito da dapsona na geração de estresse oxidativo em pacientes com hanseníase em uso de poliquimioterapia
(Universidade Federal do Pará, 2011) SCHALCHER, Taysa Ribeiro; VIEIRA, José Luiz Fernandes; http://lattes.cnpq.br/2739079559531098; MONTEIRO, Marta Chagas; http://lattes.cnpq.br/6710783324317390
Inflammation caused by Mycobacterium leprae infection and drugs with oxidative properties such as dapsone, are risk factors to induce the oxidative stress in leprosy patients. This study aims to determine plasma concentrations of dapsone in leprosy patients in use of multidrug therapy (MDT), correlating the development of oxidative stress. For the study, healthy individuals and leprosy patients were selected, followed before (D0) and after the third MDT-supervised dose (D3). The plasma concentrations of dapsone in patients under treatment (D3) were evaluated by high performance liquid chromatography. The oxidative stress was performed by methemoglobin (MetHb) and Heinz bodies determination, concentrations of reduced glutathione (GSH), nitric oxide (NO), malondialdehyde (MDA), total antioxidant capacity (TEAC) and enzymatic activity of catalase (CAT), superoxide dismutase (SOD) in blood. In the study were obtained 23 samples from leprosy patients in D0 and 13 in D3; and 20 healthy and without leprosy subjects. In patients before treatment (D0) were observed increase of NO (D0 = 18.91 ± 2.39, control = 6.86 ± 1.79mM) and significant reduction of the activity of SOD enzyme (D0 = 69.88 ± 12.26, control = 138.42 ± 14.99 nmol/mL). In MDT-treated patients (D3), the dapsone concentration in plasma was of 0,552 ± 0,037 μg / mL, and they showed Heinz bodies presence and significant increase in the MetHb percentage (D3 = 3.29 ± 0.74, control = 0051 ± 0.66%). In this patients also were observed increase of the GSH levels (D3=7.01 ± 1.9; control =3.33 ± 1.9 μg/mL) and decrease of the CAT activity (D3 = 10.29 ± 02.02, control = 19:52 2:48 ± U / g protein). However, MDA levels in D0 and D3 patients didn’t show changed, while TEAC levels, in this patients, significantly increased (D0 = 2.90 ± 0.42; D3 = 3.04 ± 0:52, control = 1.42 ± 0.18 μmol / mL). These data suggest that the MDT is mainly cause for oxidative stress, because it induced the generation of oxidative damage identified by Heinz bodies’ presence and increase in the MetHb percent.
Acesso aberto (Open Access)
O efeito in vitro dos compostos ácido alfa-lipoico e resveratrol em parâmetros do estresse oxidativo durante o uso da poliquimioterapia para hanseníase
(Universidade Federal do Pará, 2014-10-20) PESSÔA, Mariely Cristine Amador; MONTEIRO, Marta Chagas; http://lattes.cnpq.br/6710783324317390
The leprosy is an infectious disease that represents a major preoccupation in global public health in 21st century. The treatment with Multi Drug Therapy (MDT) approved by the World Health Organization (WHO) is the best treatment to Mycobacterim leprae infection; however, is one of the factors of increasing Reactive Oxygen Species (ROS) production and the development of methemoglobinemia and hemolytic anemia in these patients. The aim of this study was to verify the oxidative damage in leprosy patients receiving MDT, by evaluation of hematological and oxidative stress biomarkers, and identify the effects of in vitro treatment with antioxidants alpha-lipoic acid (ALA) and resveratrol (RSV) in antioxidant enzymes activity and prevention of methemoglobinemia. The results revealed a decrease in RBC count and reticulocytosis in patients receiving MDT during the 4th and 7th month of treatment. The percentual of methemoglobin increased since the fifth month of treatment with MDT, and the treatment with 100 μM RSV-treated and ALA-treated preserved the values similar to control group only in 4th to 6th month of MDT samples. The leprosy patients presented values of SOD activity similar to the control group and a decreased CAT activity, leading to an inbalance in the ratio of both enzymes and possibly resulting in an over-producing of H2O2. The treatment with RSV and ALA in 100 μM and 500 μM concentrations increases twice the SOD activity in 4th month patient samples; however, these concentrations did not change CAT and SOD activities found in leprosy patients. Such results demonstrate that RSV and ALA did not show antioxidant activity in installed oxidative stress, and subsequent studies are necessary to evaluate dose-dependent and time-dependent concentrations of RSV and ALA to prevent oxidative damage in chronic infectious diseases.